What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports
Podcast: Download (Duration: 1:05 — 1.5MB)
Subscribe: RSS
People who’ve had colorectal cancer and who have a mutation known as PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: There were …
